{"@context":"https://schema.org","@type":"CollectionPage","name":"Highlights From the American College of Cardiology’s Scientific Sessions: New Heart Failure Management Guidelines and more","description":"

Preventive cardiologist and conference cochair Pamela Morris, MD, discusses new heart failure management guidelines and important clinical trial results presented at the American College of Cardiology’s 2022 Scientific Sessions.

Related Content:

Highlights From the American College of Cardiology’s Scientific Sessions—New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy
Short Interfering RNA Targeting Lp(a) Production in Individuals With Elevated Plasma Lp(a)
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis
The Potential Clinical Benefit of Lowering Lipoprotein(a)

","mainEntity":{"@type":"ItemList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@type":"CreativeWork","name":"Highlights From the American College of Cardiology’s Scientific Sessions: New Heart Failure Management Guidelines and more","url":"https://www.wowfm.app/sound-player/highlights-from-the-american-college-of-cardiologys-scientific-sessions-new-heart-failure-management-guidelines-and-more-wC3LTBdCOK2#undefined"}}]}}

Highlights From the American College of Cardiology’s Scientific Sessions: New Heart Failure Management Guidelines and more

Highlights From the American College of Cardiology’s Scientific Sessions: New Heart Failure Management Guidelines and more

Episodes